University of Turku
Turku, 20540, Finland
NCT Number: NCT03730610
Obesity and insulin resistance are worldwide epidemic and taking a major public health toll. Obesity also increases the risk for cognitive impairment which is also an increasing medical, societal, and economic challenge. The ultimate goal of this proposal is to develop a statistical model to assess systemic cross-talk between brain, peripheral tissues, gut microbiota and glucose metabolism. Integrated with exercise training intervention the results will be utilized to provide disease risk profiling and personalized predictions of exercise training as a drug free treatment for insulin resistance and type 2 diabetes.
Looking for future studies?
Notify Me30 year–75 year
All sexes
Interventional
Not applicable
Turku, 20540, Finland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects are required to exercise four times a week during six months. Exercise training consists of endurance training, resistance training and high-intensity interval training adjusted to subject's fitness level.
Time frame: The change from baseline to 6 months
Brain glucose uptake (micromol/100g/min) is measured with positron emission tomography (PET) with [18F]-labelled fluoro-deoxy-glucose (FDG) tracer.
Time frame: The change from baseline to 6 months
Brain inflammation (dimensionless; standistibution volume ratio) is measured with positron emission tomography (PET) with PK11195 tracer
Time frame: The change from baseline to 6 months
Liver glucose uptake (micromol/100g/min) is measured with positron emission tomography (PET) with [18F]-labelled fluoro-deoxy-glucose (FDG) tracer
Time frame: The change from baseline to 6 months
Adipose tissue glucose uptake (micromol/100g/min) is measured with positron emission tomography (PET) with [18F]-labelled fluoro-deoxy-glucose (FDG) tracer
Time frame: The change from baseline to 6 months
Whole-body insulin sensitivity (M-value; micromol/100g/min) during the hyperinsulinemic euglycemic clamp
Time frame: The change from baseline to 6 months
Ectopic fat content (%) is measured using magnetic resonance spectroscopy (MRS)
University of Turku
Other
Modelling Systemic Cross-talk Between Brain, Gut, and Peripheral Tissues in Glucose Homeostasis: Exercise Training and Public Health
Acronym: CROSSYS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05770076
Body Weight, Glucose Metabolism Disorders
Kyiv, Ukraine
View Trial DetailsNCT03120871
Body Weight, Glucose Metabolism Disorders
Aurora, Colorado, United States
View Trial DetailsNCT04201938
Body Weight, Glucose Metabolism Disorders
Kyiv, Ukraine
View Trial DetailsNCT05765292
Body Weight, Diabetes Mellitus
Kyiv, Ukraine
View Trial Details